Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Role of melatonin in Alzheimer’s disease: From preclinical studies to novel melatonin-based therapies

Roy, J., Wong, K.Y., Aquili, L., Uddin, Md.S., Heng, B.C., Tipoe, G.L., Wong, K.H., Fung, M.L. and Lim, L.W. (2022) Role of melatonin in Alzheimer’s disease: From preclinical studies to novel melatonin-based therapies. Frontiers in Neuroendocrinology, 65 . Art. 100986.

Link to Published Version:
*Subscription may be required


Melatonin and novel melatonin-based therapies such as melatonin-containing hybrid molecules, melatonin analogues, and melatonin derivatives have been investigated as potential therapeutics against Alzheimer’s disease (AD) pathogenesis. In this review, we examine the developmental trends of melatonin therapies for AD from 1997 to 2021. We then highlight the neuroprotective mechanisms of melatonin therapy derived from preclinical studies. These mechanisms include the alleviation of amyloid-related burden, neurofibrillary tangle accumulation, oxidative stress, neuroinflammation, apoptosis, mitochondrial dysfunction, and impaired neuroplasticity and neurotransmission. We further illustrate the beneficial effects of melatonin on behavior in animal models of AD. Next, we discuss the clinical effects of melatonin on sleep, cognition, behavior, psychiatric symptoms, electroencephalography findings, and molecular biomarkers in patients with mild cognitive impairment and AD. We then explore the effectiveness of novel melatonin-based therapies. Lastly, we discuss the limitations of current melatonin therapies for AD and suggest two emerging research themes for future study.

Item Type: Journal Article
Murdoch Affiliation(s): Psychology, Counselling, Exercise Science and Chiropractic
Publisher: Elsevier
Copyright: © 2022 Elsevier Inc.
Item Control Page Item Control Page